Arcadia Biosciences (RKDA) Net Cash Flow (2014 - 2025)

Arcadia Biosciences has reported Net Cash Flow for 12 years, with the latest figure at -$839000.0 in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 351.95% year-over-year to -$839000.0; the trailing twelve-month figure through Dec 2025 stood at -$4.0 million (down 77.1% YoY), and the FY2025 full-year result was -$4.0 million, down 77.1% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$839000.0, down from -$299000.0 in the prior quarter.
• The five-year high for Net Cash Flow was $16.8 million in Q1 2021, with the low at -$9.5 million in Q2 2023.
• Historically, Net Cash Flow has averaged -$789400.0 across 5 years, with a median of -$1.7 million in 2024.
• Annual changes were most pronounced in 2021 — Net Cash Flow jumped 268.85% — and 2025, when it plunged 351.95%.
• Arcadia Biosciences' Net Cash Flow stood at -$6.8 million in 2021, then surged by 69.35% to -$2.1 million in 2022, then tumbled by 95.38% to -$4.1 million in 2023, then jumped by 108.12% to $333000.0 in 2024, then sank by 351.95% to -$839000.0 in 2025.
• The last three Net Cash Flow figures came in at -$839000.0 (Q4 2025), -$299000.0 (Q3 2025), and -$1.8 million (Q2 2025), per Business Quant data.